Cargando…
Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease
Parkinson’s disease is a neurodegenerative disorder characterized by the progressive death of dopaminergic (DA) neurons in the substantia nigra (SN), which leads to a loss of the neurotransmitter dopamine in the basal ganglia. Current treatments relieve the symptoms of the disease, but none stop or...
Autores principales: | Gonzalo-Gobernado, Rafael, Reimers, Diana, Casarejos, María José, Calatrava Ferreras, Lucía, Vallejo-Muñoz, Manuela, Jiménez-Escrig, Adriano, Diaz-Gil, Juan José, Ulzurrun de Asanza, Gonzalo M., Bazán, Eulalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287666/ https://www.ncbi.nlm.nih.gov/pubmed/32455921 http://dx.doi.org/10.3390/brainsci10050315 |
Ejemplares similares
-
Liver Growth Factor “LGF” as a Therapeutic Agent for Alzheimer’s Disease
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2020) -
Neuroprotective Role of Liver Growth Factor “LGF” in an Experimental Model of Cerebellar Ataxia
por: Calatrava-Ferreras, Lucía, et al.
Publicado: (2014) -
Immunohistochemical Study of ASC Expression and Distribution in the Hippocampus of an Aged Murine Model of Alzheimer’s Disease
por: Reimers, Diana, et al.
Publicado: (2021) -
Neuroprotective Activity of Peripherally Administered Liver Growth Factor in a Rat Model of Parkinson’s Disease
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2013) -
Liver Growth Factor (LGF) Upregulates Frataxin Protein Expression and Reduces Oxidative Stress in Friedreich’s Ataxia Transgenic Mice
por: Calatrava-Ferreras, Lucía, et al.
Publicado: (2016)